2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$26.20-$0.28 (-1.06%)
Price as of Jul 13, 2026 7:49 PM EDT- $4.1BMarket Cap
- 80.26%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$26.20-$0.28 (-1.06%)
DNLI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.48 | ||
Change | +$0.80 (+3.12%) | ||
Open | $25.70 | ||
High | $26.60 | ||
Low | $24.77 | ||
Previous Close | $25.68 | ||
Volume | 1,894,568 | ||
30-Day Average Volume | 1,914,346 | ||
1-Week Change | 2.87% | ||
1-Month Change | 22.25% | ||
1-Year Change | 80.26% | ||
3-Year Change | -9.72% | ||
5-Year Change | -60.57% | ||
Fundamentals | |||
Shares Outstanding | 158.7M | ||
Total Assets | $1.3B | ||
Market Cap | $4.1B | ||
Enterprise Value | $3.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$128.4M | ||
Free Cash Flow | -$133.7M | ||
EBIT | -$128.4M | ||
EBITDA | -$125.6M | ||
Net Working Capital | $912.6M | ||
EPS | -$0.69 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -37 | ||
PEG | -6 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue